Navigation Links
Valeant Pharmaceuticals Appoints Howard Schiller To Board Of Directors
Date:9/18/2012

MONTREAL, Sept. 18, 2012 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced the appointment of Howard Schiller, Valeant's chief financial officer, to its Board of Directors.  

Howard Schiller joined Valeant as Executive Vice President and Chief Financial Officer in December 2011 after retiring from Goldman Sachs after a 24 year career. Howard was the chief operating officer for the Investment Banking Division responsible for the management and strategy of the business. 

Howard is on the New York board of Teach for America and on the board of the Cancer Research Institute. He is also on the business advisory council of the University of Chicago Law School. Howard received his BS in economics from the Wharton School at the University of Pennsylvania and his JD from the University of Chicago Law School.

"Since Howard joined Valeant, his valuable experience and sound counsel have been invaluable to both Valeant's management team and the Board of Directors," said J. Michael Pearson, chairman and chief executive officer. "Appointing him to our board is the next logical step and one I believe will benefit our shareholders."

About Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, neurology and branded generics.  More information about Valeant Pharmaceuticals International, Inc. can be found at www.valeant.com.

Contact Information:
Laurie W. Little
949-461-6002
laurie.little@valeant.com

(Logo: http://photos.prnewswire.com/prnh/20101025/LA87217LOGO)


'/>"/>
SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Valeant Pharmaceuticals To Syndicate Incremental Loans
2. Valeant Pharmaceuticals Announces Management Change
3. Valeant Pharmaceuticals To Present At UBS Annual Global Life Sciences Conference
4. Valeant Pharmaceuticals International, Inc. Agrees To Acquire Medicis Pharmaceutical Corporation For $44.00 Per Share In Cash
5. Valeant Pharmaceuticals To Announce 2012 Second Quarter Results On August 2, 2012
6. Valeant Pharmaceuticals To Host Investor Day
7. Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results
8. Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical
9. Arena Pharmaceuticals to Present at the UBS Global Life Sciences Conference
10. AcelRx Pharmaceuticals Hires Mike A. Royal, M.D. as Chief, Clinical Affairs
11. Avanir Pharmaceuticals To Present At UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/20/2020)... ... March 21, 2020 , ... On March 19, 2020 Amramp installed a wheelchair ... Simi Valley. The ramp and platforms helped access the large intake triage trailer in ... as we install ramps that provide access to medical facilities and individual homes. This ...
(Date:3/19/2020)... Ala. (PRWEB) , ... March 19, 2020 , ... As ... healthcare experts call for us to practice social distancing and, in some cases, self-quarantine ... be especially difficult for people who have underlying mental health issues. , Cindy ...
(Date:3/16/2020)... ... 2020 , ... MCH has been tracking trends and compiling contact and demographic ... comprehensive database of district and school institution, personnel, enrollment and program data to ... The COVID-19 impact map and related data can be used by anyone as outlined ...
Breaking Medicine Technology:
(Date:3/22/2020)... ... March 21, 2020 , ... The modular construction industry, led ... (MHBA), have been working with state and federal officials on ways to support ... use of modular construction to address the nation’s affordable housing crisis well before ...
(Date:3/20/2020)... ... March 20, 2020 , ... My heart goes out to ... COVID-19. Having also lost a loved one recently through similar circumstances - underlying conditions ... days, I have felt a gamut of negative emotions just like many have: fear, ...
(Date:3/19/2020)... ... March 19, 2020 , ... For weeks, SignatureCare Emergency Center has been ... this week, it announced that while we are still short of some critical safety ... wait for our preparedness measures to be complete. , The Houston, TX based company ...
(Date:3/19/2020)... ... March 20, 2020 , ... With ICH E8(R1) set to be ... different than they do today. Be ready to implement the new guidelines. , ... readers how to leverage the revised guidelines’ quality-by-design approaches, expanded study designs and data ...
(Date:3/15/2020)... ... March 13, 2020 , ... ... There are approximately 700,000 people with autism in the world, using a conservative ... autism have access to a life-changing intervention known as Applied Behavioral Analysis. ABA ...
Breaking Medicine News(10 mins):